Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dario Palmieri

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Frontiers in Oncology|May 30, 2019
Editorial: From "Junk DNA" to Clinically Relevant Tools for Cancer Diagnosis, Staging, and Tailored Therapies: The Incredible Case of Non-Coding RNAsMarilena V Iorio, Dario Palmieri
Journal of Oncology|December 31, 2019
The CTLH Complex in Cancer Cell PlasticityNickelas Huffman, Dario Palmieri, Vincenzo Coppola
Molecular and Cellular Endocrinology|March 30, 2010
HMGA2: A pituitary tumour subtype-specific oncogene?Monica Fedele, Dario Palmieri, Alfredo Fusco
International Journal of Molecular Sciences|June 20, 2018
Scorpins in the DNA Damage ResponseDario Palmieri, Anna Tessari, Vincenzo Coppola
Pharmacogenomics and Personalized Medicine|January 10, 2014
Overview of diagnostic/targeted treatment combinations in personalized medicine for breast cancer patientsAnna Tessari, Dario Palmieri, Serena Di Cosimo
Proteins|May 6, 2022
In silico study predicts a key role of RNA-binding domains 3 and 4 in nucleolin-miRNA interactionsAvdar San, Dario Palmieri, Anjana Saxena, et al.
International Journal of Molecular Sciences|December 11, 2019
Cancer-Derived Extracellular Vesicle-Associated MicroRNAs in Intercellular Communication: One Cell's Trash Is Another Cell's TreasureJoseph Mills, Marina Capece, Emanuele Cocucci, et al.
Frontiers in Oncology|January 10, 2019
MicroRNAs for the Diagnosis and Management of Malignant Pleural Mesothelioma: A Literature ReviewGiuseppe Lo Russo, Anna Tessari, Marina Capece, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2012
The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedinDaniela D'Angelo, Eleonora Borbone, Dario Palmieri, et al.
Oncotarget|December 2, 2015
miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage responseAlessandra Cataldo, Douglas G Cheung, Andrea Balsari, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|May 30, 2019
Editorial: From "Junk DNA" to Clinically Relevant Tools for Cancer Diagnosis, Staging, and Tailored Therapies: The Incredible Case of Non-Coding RNAsMarilena V Iorio, Dario Palmieri
Journal of Oncology|December 31, 2019
The CTLH Complex in Cancer Cell PlasticityNickelas Huffman, Dario Palmieri, Vincenzo Coppola
Molecular and Cellular Endocrinology|March 30, 2010
HMGA2: A pituitary tumour subtype-specific oncogene?Monica Fedele, Dario Palmieri, Alfredo Fusco
International Journal of Molecular Sciences|June 20, 2018
Scorpins in the DNA Damage ResponseDario Palmieri, Anna Tessari, Vincenzo Coppola
Pharmacogenomics and Personalized Medicine|January 10, 2014
Overview of diagnostic/targeted treatment combinations in personalized medicine for breast cancer patientsAnna Tessari, Dario Palmieri, Serena Di Cosimo
Proteins|May 6, 2022
In silico study predicts a key role of RNA-binding domains 3 and 4 in nucleolin-miRNA interactionsAvdar San, Dario Palmieri, Anjana Saxena, et al.
International Journal of Molecular Sciences|December 11, 2019
Cancer-Derived Extracellular Vesicle-Associated MicroRNAs in Intercellular Communication: One Cell's Trash Is Another Cell's TreasureJoseph Mills, Marina Capece, Emanuele Cocucci, et al.
Frontiers in Oncology|January 10, 2019
MicroRNAs for the Diagnosis and Management of Malignant Pleural Mesothelioma: A Literature ReviewGiuseppe Lo Russo, Anna Tessari, Marina Capece, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2012
The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedinDaniela D'Angelo, Eleonora Borbone, Dario Palmieri, et al.
Oncotarget|December 2, 2015
miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage responseAlessandra Cataldo, Douglas G Cheung, Andrea Balsari, et al.
Pageof 6